← Back
Research Paper Volume 11, Issue 20 pp 9043—9059

T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma

class="figure-viewer-img"

Figure 4. Cellular viability of glioblastoma cells treated with RSPO2 and AZD5363.